Literature DB >> 11595614

Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.

S Spinella-Jaegle1, S Roman-Roman, C Faucheu, F W Dunn, S Kawai, S Galléa, V Stiot, A M Blanchet, B Courtois, R Baron, G Rawadi.   

Abstract

Several members of the transforming growth factor-beta (TGF-beta) superfamily have been demonstrated to play regulatory roles in osteoblast differentiation and maturation, but the mechanisms by which they act on different cells at different developmental stages remain largely unknown. We studied the effects of TGF-beta1 and bone morphogenetic protein-2 (BMP-2) on the differentiation/maturation of osteoblasts using the murine cell lines MC3T3-E1 and C3H10T1/2. BMP-2 induced or enhanced the expression of the osteoblast differentiation markers alkaline phosphatase (ALP) and osteocalcin (OC) in both cells. In contrast, TGF-beta1 was not only unable to induce these markers, but it dramatically inhibited BMP-2-mediated OC gene expression and ALP activity. In addition, TGF-beta1 inhibited the ability of BMP-2 to induce MC3T3-E1 mineralization. TGF-beta1 did not sensibly modify the increase of Osf2/Cbfa1 gene expression mediated by BMP-2, thus demonstrating that the inhibitory effect of TGF-beta1 on osteoblast differentiation/maturation mediated by BMP-2 was independent of Osf2/Cbfa1 gene expression. Finally, it is shown that TGF-beta1 does not affect BMP-2-induced Smad1 transcriptional activity in the mesenchymal pluripotent cells studied herein. Our data indicate that in vitro BMP-2 and TGF-beta1 exert opposite effects on osteoblast differentiation and maturation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595614     DOI: 10.1016/s8756-3282(01)00580-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  49 in total

1.  Osteoblast proliferation and differentiation on a barrier membrane in combination with BMP2 and TGFβ1.

Authors:  Richard J Miron; Nikola Saulacic; Daniel Buser; Tateyuki Iizuka; Anton Sculean
Journal:  Clin Oral Investig       Date:  2012-06-06       Impact factor: 3.573

2.  Biomechanical forces exert anabolic effects on osteoblasts by activation of SMAD 1/5/8 through type 1 BMP receptor.

Authors:  B Rath; J Nam; J Deschner; J Schaumburger; M Tingart; S Grässel; J Grifka; S Agarwal
Journal:  Biorheology       Date:  2011       Impact factor: 1.875

Review 3.  Bone regeneration by stem cell and tissue engineering in oral and maxillofacial region.

Authors:  Zhiyuan Zhang
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

4.  Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals.

Authors:  Nathan H Dormer; Milind Singh; Limin Wang; Cory J Berkland; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2010-04-09       Impact factor: 3.934

5.  Induced membrane formation in a case of infected gap nonunion of radius: Case report.

Authors:  Shameem Ahmad; Mukesh Kalra; Mariappan Selvamari
Journal:  J Clin Orthop Trauma       Date:  2013-10-08

6.  Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.

Authors:  Robyn R Mercer; Chiaki Miyasaka; Andrea M Mastro
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Response of a preosteoblastic cell line to cyclic tensile stress conditioning and growth factors for bone tissue engineering.

Authors:  Eunna Chung; Marissa Nichole Rylander
Journal:  Tissue Eng Part A       Date:  2011-11-08       Impact factor: 3.845

8.  In vitro cell response on CP-Ti surfaces functionalized with TGF-β1 inhibitory peptides.

Authors:  Pablo Sevilla; Andrea Cirera; Javier Dotor; Francisco Javier Gil; Pablo Galindo-Moreno; Conrado Aparicio
Journal:  J Mater Sci Mater Med       Date:  2018-05-23       Impact factor: 3.896

9.  Prostaglandin F2α receptor (FP) signaling regulates Bmp signaling and promotes chondrocyte differentiation.

Authors:  Joohwee Kim; Minsub Shim
Journal:  Biochim Biophys Acta       Date:  2014-12-11

10.  Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.

Authors:  Kyoko Takeuchi; Masahiro Abe; Masahiro Hiasa; Asuka Oda; Hiroe Amou; Shinsuke Kido; Takeshi Harada; Osamu Tanaka; Hirokazu Miki; Shingen Nakamura; Ayako Nakano; Kumiko Kagawa; Kenichiro Yata; Shuji Ozaki; Toshio Matsumoto
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.